Molecular biology of human papillomavirus infection and cervical cancer
The DOI matches its Crossref record; 172 of the 179 references it cites were found in a registry or an index.
Abstract
HPVs (human papillomaviruses) infect epithelial cells and cause a variety of lesions ranging from common warts/verrucas to cervical neoplasia and cancer. Over 100 different HPV types have been identified so far, with a subset of these being classified as high risk. High-risk HPV DNA is found in almost all cervical cancers (>99.7%), with HPV16 being the most prevalent type in both low-grade disease and cervical neoplasia. Productive infection by high-risk HPV types is manifest as cervical flat warts or condyloma that shed infectious virions from their surface. Viral genomes are maintained as episomes in the basal layer, with viral gene expression being tightly controlled as the infected cells move towards the epithelial surface. The pattern of viral gene expression in low-grade cervical lesions resembles that seen in productive warts caused by other HPV types. High-grade neoplasia represents an abortive infection in which viral gene expression becomes deregulated, and the normal life cycle of the virus cannot be completed. Most cervical cancers arise within the cervical transformation zone at the squamous/columnar junction, and it has been suggested that this is a site where productive infection may be inefficiently supported. The high-risk E6 and E7 proteins drive cell proliferation through their association with PDZ domain proteins and Rb (retinoblastoma), and contribute to neoplastic progression, whereas E6-mediated p53 degradation prevents the normal repair of chance mutations in the cellular genome. Cancers usually arise in individuals who fail to resolve their infection and who retain oncogene expression for years or decades. In most individuals, immune regression eventually leads to clearance of the virus, or to its maintenance in a latent or asymptomatic state in the basal cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“human papillomavirus (HPV) is thought to initiate cervical carcinoma and squamous cell carcinoma of the head and neck in part by inactivating RB through expression of the E7 oncoprotein21,22”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [21]
In the citing paper
“in HPV-induced cervical cancers, the virus initiates cancer in dividing cells in the basal layer of the epithelium, preventing their normal cell cycle exit and maturation21.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [21]
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Classification of papillomaviruses
de Villiers, E.-M., Fauquet, C., Broker, T. R., Bernard, H.-U., & zur Hausen, H. (2004) · Virology · doi:10.1016/j.virol.2004.03.033 · Cited by 3,193
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
Clifford, G. M., Smith, J. S., Plummer, M., Muñoz, N., & Franceschi, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600688 · Cited by 1,561
Barrier Function of the Skin: “La Raison d'Être” of the Epidermis
Madison, K. C. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12359.x · Cited by 1,188
Muñoz, N., Bosch, F. X., Castellsagué, X., Díaz, M., de Sanjose, S., Hammouda, D., Shah, K. V., & Meijer, C. J. L. M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20244 · Cited by 1,104
Clifford, G., Gallus, S., Herrero, R., Muñoz, N., Snijders, P., Vaccarella, S., Anh, P., Ferreccio, C., Hieu, N., Matos, E., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67069-9 · Cited by 1,093
Münger, K., Phelps, W. C., Bubb, V, Howley, P. M., & Schlegel, R. (1989) · Journal of Virology · doi:10.1128/jvi.63.10.4417-4421.1989 · Cited by 1,030
Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer
Storey, A., Thomas, M., Kalita, A., Harwood, C., Gardiol, D., Mantovani, F., Breuer, J., Leigh, I. M., Matlashewski, G., & Banks, L. (1998) · Nature · doi:10.1038/30400 · Cited by 974
Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C. E., Paavonen, J., Beckmann, A. M., DeRouen, T. A., Galloway, D. A., Vernon, D., & Kiviat, N. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271804 · Cited by 943
Research works printed but not linked: 2
- Villiers de, 2001, Taxonomic classification of papillomaviruses, Papillomavirus Rep., 12, 57
- Sorathia, 2004, The E4 protein of HPV16 Interacts with E2 and regulates the trans-activation and replication functions of E2, 318
Cited by
Items 701–800 of 1,000
Hwang, L. Y., & Moscicki, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00211-5 · Cited by 4
Rengifo-Rodríguez, J. E., Osorio, J. C., & García‐Perdomo, H. A. (2020) · Revista Mexicana de Urología · doi:10.48193/revistamexicanadeurologa.v80i4.536 · Cited by 4
Euscher, E. D., Buza, N., & Hui, P. (2021) · Pracatical anatomic pathology · doi:10.1007/978-3-030-68608-6_15 · Cited by 4
Murdock, T. A., Veras, E. F. T., Kurman, R. J., & Mazur, M. T. (2018) · Springer eBooks · doi:10.1007/978-3-319-98608-1_10 · Cited by 4
Sadeghi, R. V., Parsania, M., Sadeghizadeh, M., Haghighat, S., & Farsani, S. S. M. (2021) · Research Square · doi:10.21203/rs.3.rs-254954/v1 · Cited by 4
“The human papillomavirus genome can encode eight genes include L1, L2, E1, E2, E4, E5, E6 and E7 [6].”
BackgroundGenome Editing Against HPV-Driven Cancers: From Bench to Clinic
Çakır, M. O., Selek, M., Yilmaz, B., Özdoğan, M., & Ashrafi, G. H. (2025) · Acta Microbiologica Hellenica · doi:10.3390/amh70040041 · Cited by 3
Wang, G., Chen, F., Zhao, R., Liu, Z. M., Yang, X., & Luo, D. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1807408 · Cited by 4
La chimiokine CXCL12 et le papillomavirus humain
Brotin, É., Carthagéna, L., Chow, K. Y. C., & Bachelerie, F. (2011) · médecine/sciences · doi:10.1051/medsci/2011274002 · Cited by 3
“L’infection est souvent asymptomatique et peut se manifester par des lésions de la peau ou des muqueuses des sphères anogénitales ou orales qui, dans de rares cas associés à des virus à haut risque (par exemple HPV16 ou 18), peuvent évoluer en cancers [3].”
Background28 Humane Papillomaviren (HPV)
(2017) · Thieme eBooks · doi:10.1055/b-0037-148170 · Cited by 3
Bani, F., Bani, F., Khalilzadeh, B., Gheit, T., & Karimi, A. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143619 · Cited by 3
Is Chlamydia trachomatis a cofactor for cervical cancer
Khosla, S. (2012) · ResearchOnline at James Cook University (James Cook University) · Cited by 3
Involvement of CXCL12 Pathway in HPV-related Diseases
Okuyama, N. C. M., dos Santos, F. C., Trugilo, K. P., & de Oliveira, K. B. (2016) · AIMS Medical Science · doi:10.3934/medsci.2016.4.417 · Cited by 3
“A) [11].”
Cervical Cancer: Screening, Vaccination, and Preventive Strategies
Rossi, P. G., & Carozzi, F. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65138-3 · Cited by 4
Secondary Prevention of Uterine Cervical Cancer
Sato, S., & Itamochi, H. (2018) · InTech eBooks · doi:10.5772/intechopen.72144 · Cited by 3
Condic, M., Thiesler, T., Staerk, C., Klümper, N., Ellinger, J., EGGER, E. K., Kübler, K., Kristiansen, G., Mustea, A., & Ralser, D. J. (2022) · BMC Cancer · doi:10.1186/s12885-022-10010-x · Cited by 3
“It is estimated, that 5% of human cancers are caused by a persistent infection with high risk HPV types [25] including not only VSCC but also cervical, penile, and head and neck SCC [26].”
BackgroundHPV frequency, p16 expression and risk factors for oral leukoplakia from Córdoba, Argentina
Gilligan, G., Panico, R., Tada, C. D., Lucca, A., Brunotto, M. N., & Piemonte, E. D. (2023) · Infectio · doi:10.22354/24223794.1117 · Cited by 3
A Comparative Study of Ovarian Cancer Prediction Using Machine Learning Method
Das, A., Alam, T., Hossain, M. Z., Lamiya, H. R., & Khan, M. M. (2023) · International Conference on Electronics, Materials Engineering & Nano-Technology (IEMENTech) · doi:10.1109/iementech60402.2023.10423402 · Cited by 3
Janjua, D., Thakur, K., Aggarwal, N., Chaudhary, A., Yadav, J., Chhokar, A., Tripathi, T., Joshi, U., Senrung, A., & Bharti, A. C. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104346 · Cited by 3
Peptides for microbe-induced cancers: latest therapeutic strategies and their advanced technologies
Lin, Z., Assaraf, Y. G., & Kwok, H. F. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10197-4 · Cited by 3
Rao, A., Stosic, M. S., Mohanty, C., Suresh, D., Wang, A. R., Lee, D. L., Nickel, K. P., Chandrashekar, D. S., Kimple, R. J., Lambert, P. F., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1440836 · Cited by 3
“Human papillomaviruses (HPV) possess a compact genome encoding nine proteins, categorized as early (E) and late (L) proteins (3).”
Anal Cancer Screening: 10-Year Experience of a Specialized Outpatient Clinic
Santo, I. E., Kefleyesus, A., Chilou, C., Faes, S., Clerc, D., Hübner, M., Hahnloser, D., & Grass, F. (2025) · Cancers · doi:10.3390/cancers17020193 · Cited by 3
“Microtears or abrasions in the epithelium are common origins for exposure [10,11].”
Effect of prothymosin α and its mutants on the activity of the p53 tumor suppressor
Zakharova, N. I., Sokolov, V. V., Roudko, V., Melnikov, S. V., Vartapetian, A. B., & Evstafieva, A. G. (2008) · Molecular Biology · doi:10.1134/s002689330804016x · Cited by 3
“It is thought that E6 acts in complex with cell ubiquitin ligase E6-AP (E6-associated protein) to promote p53 degradation by the ubiquitindependent proteolytic system [25].”
BackgroundRecent Advances in Cancer Vaccines - An Update
Selvarajan, S., George, M., Suresh Kumar, S., & Dkhar, S. A. (2012) · Journal of cancer research updates · doi:10.6000/1929-2279.2012.01.02.3 · Cited by 3
The presence of HPV DNA in breast cancer
Andrejuk, S. K. –., Patyra, K. I., Macieląg, P., Mańdziuk, S., Pachnia, D., Mazurkiewicz, M., & Polz‐Dacewicz, M. (2014) · Journal of Pre-Clinical and Clinical Research · doi:10.26444/jpccr/71443 · Cited by 3
“Proteins produced in this process are involved in the cellular transformation [9].”
BackgroundKovchur, P. I., Bahidze, E. V., & Yastrebova, A. V. (2014) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-2014-2-173-180 · Cited by 3
Vermund, S. H., Bhatta, M. P., & Sahasrabuddhe, V. V. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-04579-7.00059-9 · Cited by 3
Sheaffer, A. K., Lee, M. S., Qi, H., Chaniewski, S., Zheng, X., Farr, G. A., Esposito, K. M., Harden, D., Lei, M., Schweizer, L., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155909 · Cited by 3
“While the majority of HPV infections are believed to clear spontaneously, in the longer term, low level persistence of virus infection may result in integration of the HPV genome into the host cell and subsequent transformation of the host cell by HPV oncoproteins [6].”
BackgroundHuman Papilloma Virus as a Biomarker for Personalized Head and Neck Cancer Radiotherapy
Eriksen, J. G., & Lassen, P. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-662-49651-0_7 · Cited by 5
HPV genotype analysis for women in Shaanxi Province of China
Li, J., Wang, Y. Y., Tian, X., Nan, X., Yan, T., Wang, P., Fu, Y., & Wang, G. Q. (2016) · Genetics and Molecular Research · doi:10.4238/gmr15047178 · Cited by 3
“It has closed circular double-stranded DNA with about 8000 base pairs and 3 gene domains (E, L, and UCR).”
BackgroundInfluentialEsmaeili, H. A., Pourlak, T., Ghamari, B., Shayan, F. K., Sanaat, Z., Soltani, G. G., & Fattahi, S. (2018) · Journal of Analytical Research in Clinical Medicine · doi:10.15171/jarcm.2018.010 · Cited by 3
Rojas-Cruz, A. F., & Reyes-Bermúdez, A. (2018) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2018.11.008 · Cited by 3
badpey, M. M., Bostanabad, S. Z., & Rahimi, M. K. (2019) · Iranian Journal of Medical Microbiology · doi:10.30699/ijmm.12.5.348 · Cited by 3
HRRD: a manually-curated database about the regulatory relationship between HPV and host RNA
Yan, B., Zhang, S., Yu, S., Hussain, S., Liu, T., Wang, B., Dong, X., Ma, F., & Wei, L. (2020) · Scientific Reports · doi:10.1038/s41598-020-76719-6 · Cited by 3
Krishnamurthy, K., Lindsey, A., Estrada, C.-A., Martinez, C. C., Cusnir, M., Schwartz, M. A., Sriganeshan, V., & Poppiti, R. (2020) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2020.100238 · Cited by 4
Risk Factors for Cervical Cancer Development
Gunnell, A. S. (2007) · Figshare · Cited by 5
Lorenzi, N. P. C. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2020.tde-09012020-163231 · Cited by 4
Human Papillomavirus in Head and Neck Cancer
Grimm, A. R. (2013) · Springer eBooks · doi:10.1007/978-3-642-23499-6_777 · Cited by 3
Biomarkers for detection of human papillomavirus (HPV)
Kolte, S. S., & Naaz, S. (2021) · Indian Journal of Gynecologic Oncology · doi:10.1007/s40944-021-00529-5 · Cited by 2
“lesions (HSIL) and invasive cancer represent abortive infections in which early genes E6 and E7, but not late genes L1 and L2, are expressed in all mucosal epithelial layers and the normal life cycle of the virus cannot be completed [6].”
BackgroundMichimata, R., Watari, H., Tomaru, U., Sakuragi, N., & Ishizu, A. (2013) · Pathobiology · doi:10.1159/000350423 · Cited by 2
“The E6 and E7 of high-risk HPVs are critically involved in the carcinogenesis of uterine cervical cancer [11].”
BackgroundAtlıhan, U., Yavuz, O., Ata, C., Avşar, H. A., Bıldacı, T. B., Özay, A. C., Ersak, B., Solmaz, U., & Erkılınç, S. (2025) · Medicina · doi:10.3390/medicina61040622 · Cited by 2
“It causes epithelial differentiation, which leads to the formation of condyloma [2].”
Mathematical modelling of the role of Langerhans cells in the dynamics of HPV infection
Basir, F. A., Blyuss, K. B., Raezah, A. A., Rahman, B., & Alsakaji, H. J. (2025) · Scientific Reports · doi:10.1038/s41598-025-02608-5 · Cited by 2
“Once infected, the cells E I traverse up through the epithelial column and transform into transit-amplifying infected cells E T cells that reside in supra-basal (mid-layer) of the epithelium 31,32 .”
Bergmann, L.-A., Pacholewska, A., & Schweiger, M. R. (2025) · Cancers · doi:10.3390/cancers17111740 · Cited by 3
“The HPV cell cycle regulator proteins E6 and E7 are considered as oncogenes due to their potential to degrade cellular tumor suppressors and to promote cancer development [11].”
Shan, Y., Li, F. N., Lu, P. N., Yao, Y., Sun, H. N., & Ding, Z. (2025) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/ceog45966 · Cited by 2
Microbiome, Human Papillomavirus and Cervical Carcinogenesis
Ellis, L. B., Kyrgiou, M., & Moscicki, A. (2026) · Current topics in microbiology and immunology · doi:10.1007/978-3-032-17775-9_3 · Cited by 2
Wendel, S. O., Brooke, G. M., Hu, C., Sandoval, A. R., Haratipour, P., Gu, L., Young, M., Zangi, M., Rasche, B. L., Banerjee, N. S., et al. (2026) · Cancer Research Communications · doi:10.1158/2767-9764.crc-25-0648 · Cited by 3
“Most cervical cancers are caused by persistent infection with high-risk human papillomaviruses (HPV), particularly HPV16 and HPV18, which drive oncogenesis and tumor maintenance through continual HPV oncogene (E6 and E7) expression (2, 3).”
Doorbar, J. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139046947.057 · Cited by 2
Self-citationLow mutation percentage of KRAS and BRAF genes in Brazilian anal tumors
Bidinotto, L. T., Véo, C. A. R., Loaiza, E. A. A., França, A. P. S. D., Lorenzi, A. T., Rosa, L. A. R., de Oliveira, C. M., Levi, J. E., Scapulatempo‐Neto, C., Longatto‐Filho, A., et al. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5684 · Cited by 2
“HPV infection results in high expression of cyclin-dependent kinase inhibitor 2A (p16), and disrupts the association between retinoblastoma protein and the E2F family of transcription factors, ultimately leading to cellular proliferation (10).”
Huber, L., Birk, R., KNÜTTEL, M. T., Rotter, N., Aderhold, C., Scherl, C., Lammert, A., Jungbauer, F., & Kramer, B. (2020) · Anticancer Research · doi:10.21873/anticanres.14575 · Cited by 2
Peña-López, B. O., Rincón‐Orozco, B., & Bohórquez, A. R. R. (2021) · Salud UIS · doi:10.18273/saluduis.53.e:21034 · Cited by 2
Human Papillomavirus (HPV) Entry Inhibitors
Zhu, Y. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-8702-0_14 · Cited by 2
Molecular diagnosis of human papillomavirus related to cervical cancer
Tadlaoui, K. A., & Ennaji, M. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824156-1.00013-3 · Cited by 2
Human papillomavirus infection associated with cervical cancer and other malignancies
Sakauchi, D., & Cianciarullo, A. M. (2023) · GSC Biological and Pharmaceutical Sciences · doi:10.30574/gscbps.2023.25.1.0430 · Cited by 2
Viral whole genome sequencing reveals high variations in APOBEC3 editing between HPV risk categories
Ferré, V. M., Coppée, R., Gbeasor‐Komlanvi, F. A., Vacher, S., Bridier‐Nahmias, A., Bucau, M., Salou, M., Lameiras, S., Couvelard, A., Dagnra, A. C., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.70002 · Cited by 2
The Role of Erbium–YAG in Treating Male Genital Warts
Jiryis, B., Khamaysi, K., Avitan‐Hersh, E., Shapiro, J., Dawood, M., Shehade, M., & Khamaysi, Z. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14051575 · Cited by 2
“More than 40 genotypes of this nonenveloped double-stranded DNA virus infect the anogenital area [6,7], and these are divided into low-and high-risk virus classes according to their oncogenic potential.”
Evaluation of human papillomavirus as a risk factor in prostate cancer pathogenesis
Maliye, R., Babu, S., Harris, A. E., Patke, R., Ntekim, A., Rutland, C. S., James, V. H., Mongan, N. P., Madhusudan, S., Jeyapalan, J. N., et al. (2025) · Discover Oncology · doi:10.1007/s12672-025-03236-1 · Cited by 2
“The non-coding segment is referred to as the long control region (LCR) and contains cis -elements important in viral DNA replication and transcription processes [26–28].”
Ewaisha, R., Ruffin, M. T., Williams, S. A., Chung, Y., DeGraffinreid, C. R., Paskett, E. D., Reiter, P. L., Qiu, J., Brenner, D. E., & Anderson, K. S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1612761 · Cited by 3
“HPV typing was done using the Linear Array (LA) HPV Genotyping Assay (Roche, Indiannapolis, IN), which detects 37 HPV types (6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 45, 51, 52, 53, 54, 55, 56, 58, 59, 61, 62, 64, 66, 67, 68, 69, 70, 71, 72, 73, 81, 82, 83, 84, 89, and IS39).”
InfluentialThe role of papillomavirus (HPV) in larynx cancer
Garotta, M., Occhini, A., Bertino, G., Morbini, P., & Benazzo, M. (2011) · Università degli Studi di Pavia · doi:10.6092/2039-1404.124.860 · Cited by 2
“Per verificare quindi se alla positività per HPV corrispondesse la presenza di DNA virale integrato, che rappresenta l’evento fondamentale per l’effetto oncogenetico del virus [60-61], abbiamo condotto dei test di rilevazione diretta (ibridazione in situ ed immunoistochimica per l’antigene capsidico) ed indiretta (imm…”
BackgroundOmire, A., Budambula, N. L. M., Ochieng, W., Baliach, C., Kerosi, D. O., Langat, H., Okemwa, M., Kirumbi, L., Aman, R. A., Ogutu, B., et al. (2014) · Journal of Biology Agriculture and Healthcare · Cited by 2
Lung, M. S. Y., Zhang, N., & Murray, V. (2012) · Virus Genes · doi:10.1007/s11262-012-0723-z · Cited by 2
Differences and Similarities Between HPV-Associated OPSCC and Cervical Cancer
Economopoulou, P., & Psyrri, A. K. (2015) · Springer eBooks · doi:10.1007/978-3-319-21100-8_10 · Cited by 2
Lynch, P. (2008) · Elsevier eBooks · doi:10.1016/b978-0-7234-3445-0.10023-2 · Cited by 2
Bukowska, E., Młynarczyk-Bonikowska, B., Malejczyk, M., Przedpełska, G., de Walthoffen, S. W., Młynarczyk, G., & Majewski, S. T. (2020) · Dermatology Review · doi:10.5114/dr.2020.96355 · Cited by 2
Environmental Risk Factors for Non-Melanoma Skin Cancers
Madan, V. (2009) · Springer eBooks · doi:10.1007/978-3-540-79341-0_5 · Cited by 2
Human Polyomaviruses and Papillomaviruses
Moens, U. L. (2018) · MDPI eBooks · doi:10.3390/books978-3-03897-221-1 · Cited by 2
Immunogenicity, Efficacy, Effectiveness and Overall Impact of HPV Vaccines
Lehtinen, M., Nieminen, P., Apter, D. L., Namujju, P., Natunen, K., Rana, M., & Paavonen, J. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-1988-4_10 · Cited by 2
Rosas-Murrieta, N. H., Camacho, I. H., Pea, L. M.-P., Sosa-Jurado, F., Santos-Lpez, G., Vallejo‐Ruiz, V., & Reyes‐Leyva, J. (2014) · InTech eBooks · doi:10.5772/57581 · Cited by 2
“Late genes L6 and L7 code for structural capsid proteins which encapsidate the viral genome (Figure 4) [83].”
BackgroundThe Role of HPV 16 E5 Protein and Its Interacting Partners in Cervical Cancer Cases
Sur, T. (2014) · Journal of Tumor · Cited by 2
Screening for and Genotyping of Human Papilloma Virus in Prostitutes
Keten, A., Keten, D., Odabaşı, A. B., Tezel, G. G., Güler, G., & Tümer, A. R. (2013) · Turkiye Klinikleri Journal of Medical Sciences · doi:10.5336/medsci.2011-26901 · Cited by 2
Let Sleeping Dogs Lie—Unleashing the Transforming Power of Dormant HPV
Petkova, R., Tsekov, I., Yemendzhiev, H., & Kalvatchev, Z. N. (2012) · Biotechnology & Biotechnological Equipment · doi:10.5504/bbeq.2011.0148 · Cited by 2
Preinvasive Disease of the Cervix
Creasman, W. T. (2012) · Elsevier eBooks · doi:10.1016/b978-0-323-07419-3.00001-1 · Cited by 5
Investigation of Detected by Recent Various Human Papillomavirus from General Hospital in Seoul Area
Lee, J.-B., & Park, C.-E. (2016) · Korean Journal of Clinical Laboratory Science · doi:10.15324/kjcls.2016.48.3.247 · Cited by 2
“Additionally, oncoprotein E7 also interacts with several cellular proteins other than Rb protein, and is involved in apoptosis inhibition [9,10].”
BackgroundКононова, І. Г., Oboskalova, E., Сергеевна, В. Е., & Кузина, Т. В. (2017) · Russian Bulletin of Obstetrician-Gynecologist · doi:10.17116/rosakush201717571-74 · Cited by 2
ANALYSIS OF COMPLICATED CERVICAL ECTOPY CLINICAL COURSE AND RECURRENCE
Mazur, Y., & Pyrohova, V. (2018) · EUREKA Health Sciences · doi:10.21303/2504-5679.2018.00563 · Cited by 2
“Thus, the presence of active, long-term metaplastic changes creates favorable conditions for the HPV infection, its replication and persistence in the future [9, 10], which becomes especially relevant taking into account,that the HPV infection prevalence is the highest among women aged under 25–23.”
BackgroundMolecular Cytology Applications on Gynecological Cytology
Carozzi, F., Negri, G., & Sani, C. (2018) · Springer eBooks · doi:10.1007/978-3-319-74942-6_8 · Cited by 2
Serquén-López, L. M., Iglesias-Osores, S., & Arce-Gil, Z. (2018) · Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo · doi:10.35434/rcmhnaaa.2017.104.21 · Cited by 2
Biomarkers for the Early Detection of Cervical Cancer
Neyaz, M. K., & Ahmad, S. (2019) · Springer eBooks · doi:10.1007/978-981-13-3438-2_10 · Cited by 2
Анатольевич, Е. В., Mikhailov, V. M., & Семёнович, Ч. В. (2019) · Genes and Cells · doi:10.23868/201903011 · Cited by 2
Hassan, A. Z. (2018) · Iraqi Journal of Cancer and Medical Genetics · doi:10.29409/ijcmg.v9i1.178 · Cited by 2
Human papillomavirus DNA in premenopausal and postmenopausal women
Koçtürk, S. A., & Gul, M. (2020) · Obstetrics & Gynecology International Journal · doi:10.15406/ogij.2020.11.00480 · Cited by 2
Masinde, M., Kayima, J. K., Gichuhi, W., Cheserem, E., Maranga, O. I., & Kabinga, S. K. (2022) · African Health Sciences · doi:10.4314/ahs.v22i2.11 · Cited by 2
“4 Marital status % (n) Married 20 (2) Single 60 (6) Separated 20 (2) Number of sexual partners % (n) One 70 (7) Two 20 (2) Three 10 (1) Parity % (n) Nulliparous 50 (5) 1 20 (2) 2 30 (3) Pap smear results % (n) Normal 70 (7) LSIL 10 (1) ASCUS 10 (1) AGC 10 (1)”
¿Qué tan eficaz es una intervención educativa sobre la vacuna del virus del papiloma humano?
Vaca, R. A. M., Palacios, M. I., & Troya, A. M. (2022) · Metro Ciencia · doi:10.47464/metrociencia/vol30/3/2022/6-17 · Cited by 2
Viral Interplay with the Host Sumoylation System
Deyrieux, A. F., & Wilson, V. G. (2009) · Springer eBooks · doi:10.1007/978-90-481-2649-1_18 · Cited by 2
Human papillomavirus vaccine immune response and protectivity
Petäjä, T. (2014) · Tampere University Institutional Repository (Tampere University) · Cited by 6
Exploiting Optical Contrasts for Cervical Precancer Diagnosis via Diffuse Reflectance Spectroscopy
Chang, V. (2010) · DukeSpace (Duke University) · Cited by 2
HPV 51: A candidate for type-replacement following vaccination?Preprint
Bowden, S. J., Fiander, A., & Hibbitts, S. J. (2021) · medRxiv · doi:10.1101/2021.07.27.21261121 · Cited by 2
Sitarz, K., Kopeć, J., Zawilińska, B., Klimek, M., & Szostek, S. (2021) · Acta Biochimica Polonica · doi:10.18388/abp.2020_5599 · Cited by 1
“The E1 and E2 proteins maintain expression of the oncogenic E6 and E7 proteins at a low level (Doorbar, 2006).”
BackgroundAnalysis of microbial infections with omic techniques
Tang, Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-818619-0.00013-7 · Cited by 1
FATORES DE RISCO E PREVALÊNCIA DO HPV EM COMUNIDADES QUILOMBOLAS: UMA REVISÃO DA LITERATURA
Sousa, I. B. P., Lima, L. F. C., Silva, B. A. O., de Andrade, K. C., Berrêdo, G. B. L. C., Paz, M. L., Ferreira, C. S., & Júnior, I. B. P. D. A. (2025) · Revista Foco · doi:10.54751/revistafoco.v18n4-150 · Cited by 1
Prediction of high-risk human papillomavirus after conization by machine learning methods
Özçekiç, E., Lafcı, D., Usta, A., Çetin, O., Özel, Y., & Kozak, G. (2025) · Journal of Immunology and Clinical Microbiology · doi:10.58854/jicm.1609786 · Cited by 1
Strickland, K. C., Wallen, Z. D., Ko, H. C., Green, M. F., Dillard, A., Pabla, S., Hastings, S. M., Roos, A., Jensen, T. J., Eisenberg, M. T., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-15156-9 · Cited by 1
Tamai, K., Kinjo, S., Taguchi, A., Nagasaka, K., Yoshimoto, D., Duong, A. Q., Yamamoto, Y., Iuchi, H., Mori‐Uchino, M., Sone, K., et al. (2025) · Viruses · doi:10.3390/v17101344 · Cited by 1
“In HPV-infected cells, HPV-derived E6 and E7 oncoproteins inactivate p53 and pRb tumor suppressor proteins, which eventually cause resistance to apoptosis and promote cell proliferation [2,4,5].”
Immunotherapy for Cervical Cancer
Gutiérrez‐Hoya, A., Valle‐Mendiola, A., & Soto‐Cruz, I. (2025) · Springer eBooks · doi:10.1007/978-3-032-00769-8_234 · Cited by 1
Masum, M. H. U., Parvin, R., Heema, H. P., Akter, A., & Ferdous, J. (2025) · Cancer Reports · doi:10.1002/cnr2.70434 · Cited by 1
A discrete nonlinear model for HPV immune suppression and evasion
Solís, F. J., & Gonzalez, L. M. (2026) · Mathematical Biosciences · doi:10.1016/j.mbs.2026.109622 · Cited by 1
Synergism on Cancer Development of Human Papillomavirus and Chlamydia Trachomatis Co-Infection
Tang, E., Liao, Y., Wang, Z., Zhao, L., Yang, M., Chen, Y., & Tang, S. (2026) · Reproductive Sciences · doi:10.1007/s43032-025-02042-y · Cited by 1
In Vitro Model Characterizing Carcinogenic Progression of HPV-Positive Oropharyngeal Cancer
Tejeda, J. A., Chatterjee, S., & Meyers, C. (2026) · Cancers · doi:10.3390/cancers18040683 · Cited by 1
“…systems, and consistent with prior findings demonstrating that E6-mediated p53 loss and E7-dependent disruption of pRb are hallmark functional readouts of high-risk HPV activity, we used p53 reduction and pRb loss as surrogate markers of E6 and E7 function in our established model [61–63].”
Time-lapsed colposcopy image-based segmentation of cervical lesion areas
Yan, L., Wang, Z., Shen, X., Yang, J., Guo, Y., Zhou, W., Zhao, T., Wang, Q., & Ma, X. (2026) · Scientific Reports · doi:10.1038/s41598-026-43146-y · Cited by 2
Rottenberg, J. T., Liu, X., ElSadec, M. Y., Berenson, A., Soto-Ugaldi, L. F., Corban, J. E., Dexheimer, P. J., Hass, M. R., Santoso, C., Yin, C., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-77780-x · Cited by 1
AKNA as Genetic Risk Factor for Cervical Intraepithelial Neoplasia and Cervical Cancer
Torres-Poveda, K., Ana, I., Bahena-Román, M., Lagunas-Martínez, A., & Madrid-Mari, V. (2012) · InTech eBooks · doi:10.5772/33310 · Cited by 1
“The full cycle that includes viral DNA synthesis, production of viral capsid proteins and assembly of virions, occurs selectively in terminally differentiated keratinocytes (Doorbar, 2006).”
Background
Metadata
- Authors
- Doorbar, J.
- Affiliations
- National Institute for Medical Research (GB)
- Corresponding author
- Doorbar, John
- ORCID
- Doorbar, John
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2006-04-11
- Volume
- 110
- Issue
- 5
- Pages
- 525-541
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2052489835
- Cited by
- 1,072
- References
- 179
- Citations by year
- 2026: 30 · 2025: 35 · 2024: 34 · 2023: 41 · 2022: 51 · 2021: 43 · 2020: 52 · 2019: 45 · 2018: 60 · 2017: 55 · 2016: 58 · 2015: 64 · 2014: 73 · 2013: 98 · 2012: 83
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Keywords
- human papillomavirus, cervical cancer, HPV16, high-risk HPV, viral gene expression, cervical neoplasia, cervical transformation zone, E6 oncoprotein, E7 oncoprotein, retinoblastoma protein, p53 degradation, PDZ domain proteins, abortive infection, viral latency, immune clearance
- MeSH terms
- Uterine Cervical Neoplasms, Female, Humans, Precancerous Conditions, Virus Latency, Disease Progression, Papillomaviridae, Papillomavirus Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.